治疗大曼彻斯特地区国家医疗服务系统工作人员的烟草依赖:对定制数字服务的评估

Kavita Sivabalah MB BCh BAO, MRCP (UK) , David Crane PhD , Samantha Neville , Mandy Hancock MSc , Anthony Ryan , Bincy Ajay , Jane Coyne BA , Elizabeth Benbow , Andrea Crossfield MSc , Sebastian Bate MMath , Matthew Evison MD
{"title":"治疗大曼彻斯特地区国家医疗服务系统工作人员的烟草依赖:对定制数字服务的评估","authors":"Kavita Sivabalah MB BCh BAO, MRCP (UK) ,&nbsp;David Crane PhD ,&nbsp;Samantha Neville ,&nbsp;Mandy Hancock MSc ,&nbsp;Anthony Ryan ,&nbsp;Bincy Ajay ,&nbsp;Jane Coyne BA ,&nbsp;Elizabeth Benbow ,&nbsp;Andrea Crossfield MSc ,&nbsp;Sebastian Bate MMath ,&nbsp;Matthew Evison MD","doi":"10.1016/j.jtocrr.2024.100674","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Treating tobacco dependency in National Health Service (NHS) workers delivers substantial benefits at an individual, population, and health care system level. We report the outcomes from the Greater Manchester Integrated Care Partnership’s tobacco dependency treatment program for NHS workers which includes 6-months’ access to behavioral support and 12 weeks of treatment through a digital application.</p></div><div><h3>Methods</h3><p>Aggregate results for all participants across the program from January 1, 2022, to September 1, 2023, are reported including a deep-dive evaluation of 300 participants recruited to provide chemically validated outcomes.</p></div><div><h3>Results</h3><p>A total of 1567 NHS workers participated in the program within the evaluation period, completing 24,048 sessions with specialist advisors within the application, ordering 18,710 nicotine vape liquids, 6927 nicotine patches, and 297 short-acting nicotine products. Users reported achieving 89,464 smoke-free days, 1,258,069 less cigarettes smoked, and a financial saving of £622,231. The deep-dive evaluation revealed a CO-verified 12-week abstinence rate of 37% (111 of 300).</p></div><div><h3>Conclusion</h3><p>This evaluation provides assurance of clinical effectiveness within a bespoke digital tobacco dependency treatment program for NHS workers across an Integrated Care Partnership.</p></div>","PeriodicalId":17675,"journal":{"name":"JTO Clinical and Research Reports","volume":null,"pages":null},"PeriodicalIF":3.0000,"publicationDate":"2024-04-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2666364324000444/pdfft?md5=7c3c7a54d194921b994c0771480aff7a&pid=1-s2.0-S2666364324000444-main.pdf","citationCount":"0","resultStr":"{\"title\":\"Treating Tobacco Dependency in National Health Service Workers in Greater Manchester: An Evaluation of a Bespoke Digital Service\",\"authors\":\"Kavita Sivabalah MB BCh BAO, MRCP (UK) ,&nbsp;David Crane PhD ,&nbsp;Samantha Neville ,&nbsp;Mandy Hancock MSc ,&nbsp;Anthony Ryan ,&nbsp;Bincy Ajay ,&nbsp;Jane Coyne BA ,&nbsp;Elizabeth Benbow ,&nbsp;Andrea Crossfield MSc ,&nbsp;Sebastian Bate MMath ,&nbsp;Matthew Evison MD\",\"doi\":\"10.1016/j.jtocrr.2024.100674\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>Treating tobacco dependency in National Health Service (NHS) workers delivers substantial benefits at an individual, population, and health care system level. We report the outcomes from the Greater Manchester Integrated Care Partnership’s tobacco dependency treatment program for NHS workers which includes 6-months’ access to behavioral support and 12 weeks of treatment through a digital application.</p></div><div><h3>Methods</h3><p>Aggregate results for all participants across the program from January 1, 2022, to September 1, 2023, are reported including a deep-dive evaluation of 300 participants recruited to provide chemically validated outcomes.</p></div><div><h3>Results</h3><p>A total of 1567 NHS workers participated in the program within the evaluation period, completing 24,048 sessions with specialist advisors within the application, ordering 18,710 nicotine vape liquids, 6927 nicotine patches, and 297 short-acting nicotine products. Users reported achieving 89,464 smoke-free days, 1,258,069 less cigarettes smoked, and a financial saving of £622,231. The deep-dive evaluation revealed a CO-verified 12-week abstinence rate of 37% (111 of 300).</p></div><div><h3>Conclusion</h3><p>This evaluation provides assurance of clinical effectiveness within a bespoke digital tobacco dependency treatment program for NHS workers across an Integrated Care Partnership.</p></div>\",\"PeriodicalId\":17675,\"journal\":{\"name\":\"JTO Clinical and Research Reports\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2024-04-06\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2666364324000444/pdfft?md5=7c3c7a54d194921b994c0771480aff7a&pid=1-s2.0-S2666364324000444-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"JTO Clinical and Research Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2666364324000444\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"JTO Clinical and Research Reports","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2666364324000444","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

导言:治疗国民健康服务(NHS)工作人员的烟草依赖会在个人、人群和医疗保健系统层面带来巨大的益处。我们报告了大曼彻斯特地区综合医疗合作机构针对国家医疗服务体系工作人员开展的烟草依赖治疗项目的结果,该项目包括为期6个月的行为支持和12周的数字应用治疗。方法报告了2022年1月1日至2023年9月1日期间该项目所有参与者的综合结果,包括对招募的300名参与者进行的深入评估,以提供经化学验证的结果。结果在评估期间,共有 1567 名国家医疗服务系统工作人员参与了该计划,在应用程序中与专家顾问完成了 24,048 次对话,订购了 18,710 支尼古丁 vape 液体、6927 块尼古丁贴片和 297 件短效尼古丁产品。用户报告称,他们实现了 89,464 个无烟日,减少了 1,258,069 支香烟,节省了 622,231 英镑。深度评估显示,经 CO 验证的 12 周戒烟率为 37%(300 人中有 111 人戒烟)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Treating Tobacco Dependency in National Health Service Workers in Greater Manchester: An Evaluation of a Bespoke Digital Service

Introduction

Treating tobacco dependency in National Health Service (NHS) workers delivers substantial benefits at an individual, population, and health care system level. We report the outcomes from the Greater Manchester Integrated Care Partnership’s tobacco dependency treatment program for NHS workers which includes 6-months’ access to behavioral support and 12 weeks of treatment through a digital application.

Methods

Aggregate results for all participants across the program from January 1, 2022, to September 1, 2023, are reported including a deep-dive evaluation of 300 participants recruited to provide chemically validated outcomes.

Results

A total of 1567 NHS workers participated in the program within the evaluation period, completing 24,048 sessions with specialist advisors within the application, ordering 18,710 nicotine vape liquids, 6927 nicotine patches, and 297 short-acting nicotine products. Users reported achieving 89,464 smoke-free days, 1,258,069 less cigarettes smoked, and a financial saving of £622,231. The deep-dive evaluation revealed a CO-verified 12-week abstinence rate of 37% (111 of 300).

Conclusion

This evaluation provides assurance of clinical effectiveness within a bespoke digital tobacco dependency treatment program for NHS workers across an Integrated Care Partnership.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
4.20
自引率
0.00%
发文量
145
审稿时长
19 weeks
期刊最新文献
Radiotherapy Improves Survival in NSCLC After Oligoprogression on Immunotherapy: A Cohort Study Analysis of Baseline Molecular Factors Associated With the Risk of Central Nervous System Progression Among Alectinib-Treated Patients With ALK–Positive NSCLC Regarding: “Olloni A, et al. Heart and Lung Dose as Predictors of Overall Survival in Patients With Locally Advanced Lung Cancer. A National Multicenter Study” Synchronous Oligometastasis and Oligoprogression as a Prognostic Marker in Patients With Extensive-Stage SCLC Treated With a Combination of Immune-Checkpoint Inhibitor and Chemotherapy (HOT2301) The Whole Picture of First-Line Osimertinib for EGFR Mutation-Positive Advanced NSCLC: Real-World Efficacy, Safety, Progression Pattern, and Posttreatment Therapy (Reiwa Study)
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1